Hyperfine Announces 10 Abstracts At RSNA, Highlighting The Expanding Utility And Potential Of Portable MR Brain Imaging In Diverse Clinical And Research Settings
Hyperfine Announces 10 Abstracts At RSNA, Highlighting The Expanding Utility And Potential Of Portable MR Brain Imaging In Diverse Clinical And Research Settings
The breadth of data being presented at the premier radiology meeting of 2024 illustrates the increasing relevance of portable, ultra-low-field MR brain imaging.
2024年首屈一指的放射學會議上展示的數據廣度顯示了便攜式超低場MR腦成像日益相關的重要性。
Hyperfine, Inc. (NASDAQ:HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop system—today announced that ten scientific abstracts highlighting ultra-low-field imaging will be presented at the Radiological Society of North America (RSNA) 2024 Annual Meeting in Chicago. For Hyperfine, this marks the largest number of presentations at RSNA to date, underscoring the growing interest in and expanding applications of the Swoop system across varied professional healthcare environments.
Hyperfine, Inc.（納斯達克：HYPR），是一家開創性健康科技公司，它通過首個獲得FDA批准的便攜式磁共振（MR）腦成像系統——Swoop系統，重新定義了腦成像。今天，Hyperfine宣佈將在2024年在芝加哥舉行的北美放射學會（RSNA）年會上展示十篇突出超低場成像的科學摘要。這標誌着Hyperfine在RSNA上展示的演講數量創下歷史新高，突顯了對Swoop系統在專業醫療環境中日益增長的興趣和擴展應用。
譯文內容由第三人軟體翻譯。
